{"title":"CDC, FDA lift pause of J&J vaccine after advisors vote in support of use [Updated]","link":"https://arstechnica.com/?p=1759864","date":1619215800000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269-800x522.jpeg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269.jpeg\">Enlarge</a> <span>/</span> Boxes of Johnson &amp; Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/johnson-johnson-covid-19-vaccine-boxes-are-seen-at-a-news-photo/1232239269?adppopup=true\">Getty | Paul Hennessy</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p><strong>Update 7:00 pm EDT:Â </strong>The Centers for Disease Control and Prevention and the Food and Drug Administration announced late Friday that the pause on the use of Johnson &amp; Johnson's one-shot COVID-19 vaccine is now lifted.</p>\n<p>The announcement comes just hours after a panel of CDC advisors voted largely in favor of resuming use, reaffirming its recommendation that it be used in all adults.</p>\n<p>The two agencies paused use on April 13 after six women developed dangerous blood clots after receiving the vaccine. Though the CDC confirmed nine additional cases during the 11-day pause, the agencies and their advisors determined that the benefits of the vaccine greatly outweigh risks of the extremely rare condition.</p></div><p><a href=\"https://arstechnica.com/?p=1759864#p3\">Read 17 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1759864&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"60409e97823ff1cab5a72f156c3addb144f48500533f57cea8c16cf513002e2b","category":"Tech"}